# Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma

> **NCT06185751** · PHASE1 · RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 25 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **BIOLOGICAL:** WS-CART-CS1
- **DRUG:** Lymphodepleting chemotherapy

## Key facts

- **NCT ID:** NCT06185751
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-22
- **Primary completion:** 2029-08-31
- **Final completion:** 2040-08-31
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06185751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06185751, "Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06185751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*